Skip to main content
. 2025 Jun 20;312(3):919–925. doi: 10.1007/s00404-025-08084-6

Table 4.

Post-discharge follow-up and management of the study population

Variables Proliferative phase
(n = 80)
Secretory phase (n = 63) P value
Post-discharge complications 0 0 /
Postoperative pharmacological intervention 36 (45.0%) 37 (50.7%) 0.482
LNG-IUS long-term management 18 (22.5%) 14 (22.2%) > 0.999
Recurrence 31 (38.8%) 9 (14.3%) 0.001**

The values are presented as mean ± standard or number (percentage)

*P < 0.05, **P < 0.01, ***P < 0.001